Clinical and microbiological factors associated with early patient mortality from methicillinresistant Staphylococcus aureus bacteremia
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Methicillin-resistant Staphylococcus aureus bacteremia (MRSAB) is a major bloodstream infection with a high mortality rate. Identification of factors associated with early mortality in MRSAB patients would be useful for predicting prognosis and developing new therapeutic options. Methods: A prospective cohort of MRSAB patients was examined between August 2008 and June 2011. Early and late mortality was defined as death within 2 and 28 days of blood culture, respectively. The clinical and microbiological characteristics in the early and late mortality and survival groups were compared. Risk factors associated with severe sepsis or septic shock were also investigated. Results: A total of 385 adult MRSAB patients whose S. aureus isolates were available were enrolled; of these patients, 25 patients (6.5%) and 50 (13%) died early and late, respectively. Compared with both the late-mortality group and the survival group, severe sepsis or septic shock was a statistically significant independent risk factor associated with early mortality. Rapidly or ultimately fatal McCabe and Jackson classification (adjusted odds ratio [aOR], 1.94; 95% confidence interval [CI], 1.25 to 3.02) and pneumonia (aOR, 2.04; 95% CI, 1.03 to 4.02) were independently associated with severe sepsis or septic shock. A vancomycin minimum inhibitory concentration (MIC) ≥ 1.5 μg/mL was associated with a reduced incidence of severe sepsis or septic shock (aOR, 0.53; 95% CI, 0.34 to 0.84). Conclusions: Severity of illness seems to be the most important risk factor associated with early mortality in MRSAB. Although vancomycin MIC was not independently associated with early mortality, reduced vancomycin susceptibility appears to be linked to reduced disease severity.
Abstract
Background/Aims: Methicillin-resistant Staphylococcus aureus bacteremia (MRSAB) is a major bloodstream infection with a high mortality rate. Identification of factors associated with early mortality in MRSAB patients would be useful for predicting prognosis and developing new therapeutic options. Methods: A prospective cohort of MRSAB patients was examined between August 2008 and June 2011. Early and late mortality was defined as death within 2 and 28 days of blood culture, respectively. The clinical and microbiological characteristics in the early and late mortality and survival groups were compared. Risk factors associated with severe sepsis or septic shock were also investigated. Results: A total of 385 adult MRSAB patients whose S. aureus isolates were available were enrolled; of these patients, 25 patients (6.5%) and 50 (13%) died early and late, respectively. Compared with both the late-mortality group and the survival group, severe sepsis or septic shock was a statistically significant independent risk factor associated with early mortality. Rapidly or ultimately fatal McCabe and Jackson classification (adjusted odds ratio [aOR], 1.94; 95% confidence interval [CI], 1.25 to 3.02) and pneumonia (aOR, 2.04; 95% CI, 1.03 to 4.02) were independently associated with severe sepsis or septic shock. A vancomycin minimum inhibitory concentration (MIC) ≥ 1.5 μg/mL was associated with a reduced incidence of severe sepsis or septic shock (aOR, 0.53; 95% CI, 0.34 to 0.84). Conclusions: Severity of illness seems to be the most important risk factor associated with early mortality in MRSAB. Although vancomycin MIC was not independently associated with early mortality, reduced vancomycin susceptibility appears to be linked to reduced disease severity.
참고문헌 (37)
- Weinstein MP, "The clinical significance of positive blood cultures in the 1990s : a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults", Clin Infect Dis, 24, pp.584~602 (1997)
- Laupland KB, "Staphylococcus aureus bloodstream infections : risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006", J Infect Dis, 198, pp.336~343 (2008)
- Gasch O, "Epidemiology of methicillin-resistant Staphylococcus aureus(MRSA)bloodstream infection : secular trends over 19years at a university hospital", Medicine (Baltimore), 90, pp.319~327 (2011)
- Paul M, "Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia", J Antimicrob Chemother, 65, pp.2658~2665 (2010)
- Dantes R, "National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011", JAMA Intern Med, 173, pp.1970~1978 (2013)
- Gasch O, "Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia", J Antimicrob Chemother, 68, pp.1423~1430 (2013)
- Wang JT, "Prognosis of patients with methicillin-resistant Staphylococcus aureus bloodstream infection treated with teicoplanin : a retrospective cohort study investigating effect of teicoplanin minimum inhibitory concentrations", BMC Infect Dis, 13, pp.182~ (2013)
- Moore CL, "Prediction of failure in vancomycin-treated methicillin-resistant Staphylococcus aureus bloodstream infection : a clinically useful risk stratification tool", Antimicrob Agents Chemother, 55, pp.4581~4588 (2011)
- Soriano A, "Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia", Clin Infect Dis, 46, pp.193~200 (2008)
- Walraven CJ, "Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia", J Antimicrob Chemother, 66, pp.2386~2392 (2011)
- Gasch O, "Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection : impact on outcome of host, microorganism and therapy", Clin Microbiol Infect, 19, pp.1049~1057 (2013)
- Kim J, "Impact of a computerized alert system for bacteremia notification on the appropriate antibiotic treatment of Staphylococcus aureus bloodstream infections", Eur J Clin Microbiol Infect Dis, 32, pp.937~945 (2013)
- Wi YM, "High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia", Int J Antimicrob Agents, 40, pp.108~113 (2012)
- Wysocki M, "Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections : prospective multicenter randomized study", Antimicrob Agents Chemother, 45, pp.2460~2467 (2001)
- Levy MM, "2001 SCCM", ESICM, ATS, pp.SIS international sepsis definitions conference, Intensive Care Med[DOI]
- Friedman ND, "Health care: associated bloodstream infections in adults. A reason to change the accepted definition of community-acquired infections", Ann Intern Med, 137, pp.791~797 (2002)
- Bone RC, "Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP", SCCM Consensus Conference Committee. American College of Chest Physicians, Chest, pp.1992, 101[DOI]
- Paterson DL, "International prospective study of Klebsiella pneumoniae bacteremia : implications of extended-spectrum beta-lactamase production in nosocomial Infections", Ann Intern Med, 140, pp.26~32 (2004)
- Charlson ME, "A new method of classifying prognostic comorbidity in longitudinal studies : development and validation", J Chronic Dis, 40, pp.373~383 (1987)
- McCabe WR, "Gram-negative bacteremia. l. Etiology and ecology", Arch Intern Med, 110, pp.847~855 (1962)
- Kim SH, "Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci", Clin Infect Dis, 37, pp.794~799 (2003)
- Rybak M, "Therapeutic monitoring of vancomycin in adult patients : a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists", Am J Health Syst Pharm, 66, pp.82~98 (2009)
- Clinical and Laboratory Standards Institute, "Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement", Clinical and Laboratory Standards Institute, ~ (2008)
- Oliveira DC, "Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus", Antimicrob Agents Chemother, 46, pp.2155~2161 (2002)
- Diep BA, "Roles of 34 virulence genes in the evolution of hospital-and community-associated strains of methicillin-resistant Staphylococcus aureus", J Infect Dis, 193, pp.1495~1503 (2006)
- Peacock SJ, "Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus", Infect Immun, 70, pp.4987~4996 (2002)
- Enright MC, "Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus", J Clin Microbiol, 38, pp.1008~1015 (2000)
- Schweizer ML, "Increased mortality with accessory gene regulator(agr)dysfunction in Staphylococcus aureus among bacteremic patients", Antimicrob Agents Chemother, 55, pp.1082~1087 (2011)
- Wootton M, "A modified population analysis profile(PAP)method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital", J Antimicrob Chemother, 47, pp.399~403 (2001)
- Park HJ, "Clinical significance of Staphylococcus aureus bacteremia in patients with liver cirrhosis", Eur J Clin Microbiol Infect Dis, 31, pp.3309~3316 (2012)
- Rieg S, "Mortality of S. aureus bacteremia and infectious diseases specialist consultation: a study of 521 patients in Germany", J Infect, 59, pp.232~239 (2009)
- Claria J, "Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites", Gastroenterology, 115, pp.147~156 (1998)
- Bilzer M, "Role of Kupffer cells in host defense and liver disease", Liver Int, 26, pp.1175~1186 (2006)
- Peleg AY, "Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection", J Infect Dis, 199, pp.532~536 (2009)
- Cui L, "Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus", Antimicrob Agents Chemother, 50, pp.428~438 (2006)
- Pfeltz RF, "Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds", Antimicrob Agents Chemother, 44, pp.294~303 (2000)
- Park KH, "Community-associated MRSA strain ST72-SCCmecIV causing bloodstream infections : clinical outcomes and bacterial virulence factors", J Antimicrob Chemother, 70, pp.1185~1192 (2015)